Chemical Component Summary

NameN-[3-[(4S)-2-azanyl-4-methyl-1,3-thiazin-4-yl]-4-fluoranyl-phenyl]-5-cyano-pyridine-2-carboxamide
Identifiers~{N}-[3-[(4~{S})-2-azanyl-4-methyl-1,3-thiazin-4-yl]-4-fluoranyl-phenyl]-5-cyano-pyridine-2-carboxamide
FormulaC18 H14 F N5 O S
Molecular Weight367.4
TypeNON-POLYMER
Isomeric SMILESC[C@]1(C=CSC(=N1)N)c2cc(ccc2F)NC(=O)c3ccc(cn3)C#N
InChIInChI=1S/C18H14FN5OS/c1-18(6-7-26-17(21)24-18)13-8-12(3-4-14(13)19)23-16(25)15-5-2-11(9-20)10-22-15/h2-8,10H,1H3,(H2,21,24)(H,23,25)/t18-/m0/s1
InChIKeyVLLFGVHGKLDDLW-SFHVURJKSA-N

Chemical Details

Formal Charge0
Atom Count40
Chiral Atom Count1
Bond Count42
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB15307 
NameAtabecestat
Groups investigational
DescriptionAtabecestat is under investigation in clinical trial NCT02211079 (A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates).
Synonyms
  • JNJ-54861911
  • Atabecestat
CategoriesSulfur Compounds
CAS number1200493-78-2

Related Resource References

Resource NameReference
Pharos CHEMBL3916243
PubChem 68254185
ChEMBL CHEMBL3916243